GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SQI Diagnostics Inc (FRA:XSQ) » Definitions » Cyclically Adjusted Price-to-FCF

SQI Diagnostics (FRA:XSQ) Cyclically Adjusted Price-to-FCF : (As of May. 24, 2024)


View and export this data going back to 2010. Start your Free Trial

What is SQI Diagnostics Cyclically Adjusted Price-to-FCF?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted Price-to-FCF for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


SQI Diagnostics Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for SQI Diagnostics's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SQI Diagnostics Cyclically Adjusted Price-to-FCF Chart

SQI Diagnostics Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

SQI Diagnostics Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of SQI Diagnostics's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, SQI Diagnostics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SQI Diagnostics's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SQI Diagnostics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where SQI Diagnostics's Cyclically Adjusted Price-to-FCF falls into.



SQI Diagnostics Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

SQI Diagnostics's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2023 is calculated as:

For example, SQI Diagnostics's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=-0.001/122.7021*122.7021
=-0.001

Current CPI (Mar. 2023) = 122.7021.

SQI Diagnostics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201306 -0.020 97.182 -0.025
201309 -0.024 97.419 -0.030
201312 -0.017 96.945 -0.022
201403 -0.011 98.604 -0.014
201406 -0.020 99.473 -0.025
201409 -0.015 99.394 -0.019
201412 -0.017 98.367 -0.021
201503 -0.019 99.789 -0.023
201506 -0.017 100.500 -0.021
201509 -0.015 100.421 -0.018
201512 -0.013 99.947 -0.016
201603 -0.016 101.054 -0.019
201606 -0.010 102.002 -0.012
201609 -0.010 101.765 -0.012
201612 -0.008 101.449 -0.010
201703 -0.015 102.634 -0.018
201706 -0.006 103.029 -0.007
201709 -0.009 103.345 -0.011
201712 -0.010 103.345 -0.012
201803 -0.010 105.004 -0.012
201806 -0.005 105.557 -0.006
201809 -0.009 105.636 -0.010
201812 -0.006 105.399 -0.007
201903 -0.005 106.979 -0.006
201906 -0.003 107.690 -0.003
201909 -0.008 107.611 -0.009
201912 -0.006 107.769 -0.007
202003 -0.005 107.927 -0.006
202006 -0.003 108.401 -0.003
202009 -0.004 108.164 -0.005
202012 -0.003 108.559 -0.003
202103 -0.007 110.298 -0.008
202106 -0.005 111.720 -0.005
202109 -0.005 112.905 -0.005
202112 -0.007 113.774 -0.008
202203 -0.019 117.646 -0.020
202206 -0.003 120.806 -0.003
202209 -0.005 120.648 -0.005
202212 -0.003 120.964 -0.003
202303 -0.001 122.702 -0.001

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


SQI Diagnostics  (FRA:XSQ) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


SQI Diagnostics Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of SQI Diagnostics's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


SQI Diagnostics (FRA:XSQ) Business Description

Traded in Other Exchanges
N/A
Address
36 Meteor Drive, Toronto, ON, CAN, M9W 1A4
SQI Diagnostics Inc is the leader in the field of lung health. The company develops and manufactures respiratory health and precision medicine tests that run on SQI's automated systems. The company is developing tests to simplify and improve COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its geographical segments are the United States, Canada, and Europe. Canada accounts for more than half of its revenues.

SQI Diagnostics (FRA:XSQ) Headlines

No Headlines